Wegener’s
granulomatosis
Necrotizing granulomatous inflammation that affects small and medium sized
blood vessels, upper and lower respiratory tract, and kidneys
Clinical features
Eyes
- involved in 25-50%
- conjunctivitis, episcleritis, scleritis,
uveitis, vasculitis of retina, optic
neuritis, occlusion of central retinal artery
- proptosis due to granulomatous pseudotumours of the orbit
ENT
- conductive or sensorineural deafness
- otitis; may lead to mastoiditis
- persistent nasal congestion
- nasal mucosal thickening
- ulceration and crusting of nasal mucosa; may lead to perforation of septum and
facial bone destruction
- chondritis of nose leads saddle nose deformity
- subglottic region is most frequently involved area of tracheobronchial tree.
Ulcerative lesions may lead to subglottic stenosis
causing respiratory distress.
May be confused with asthma
Lung
- usually asymptomatic
- single/multiple nodules or masses (+/-
cavitation) are most frequent
manifestations
- pulmonary infiltrates rare and should alert clinician to the possibility of
alveolar haemorrhage
- pleural effusion in 10%
Renal
- usual form of involvement is a focal segmental glomerulonephritis
- if untreated renal involvement may progress to irreversible renal
insufficiency
Skin
- urticarial lesions
- papules
- vesicles
- erythema
- petechiae
- ulcerative lesions
- pyoderma gangrenosum
Joints
- migratory arthralgias involving single or multiple joints
- symmetrical polyarthritis
CNS
- mononeuritis multiplex
- cranial nerve palsies
Diagnosis
- requires histological proof for definitive diagnosis
- positive cytoplasmic staining antineutrophil cytoplasmic antibody test has
specificity of > 90% for Wegener's
- mild normochromic, normocytic anaemia
- thrombocytosis in about 1/3
- WCC usually normal, occasionally elevated
- ESR and CRP raised
- high titres of rheumatoid factor in 1/2
- urinalysis: red cells and casts in those with renal involvement
- sinus XR
- CXR abnormal in 55-95% of cases
Treatment
- cyclophosphamide and prednisone orally
- IV boluses of cyclophosphamide for those not controlled with oral regime
Further reading
http://vasculitis.med.jhu.edu/wg.htm
© Charles Gomersall December 1999
|